No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
55 and older
Sex
Any
Study type
Observational
Participants needed
100 (estimated)
Sponsor
Yale University · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
The purpose of this research study is to examine the effect of social connectedness on the brain. Study procedures include one Magnetic Resonance Imaging (MRI) or functional Magnetic Resonance Imaging (fMRI) scan, one Positron Emission Tomography (PET) scan, one Magnetic Resonance Spectroscopy (MRS) scan, an electroencephalogram (EEG), and in-person and phone call follow-ups.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
* able to give written informed consent
* age 55+
* English speaking
Exclusion Criteria:
* contraindication to MRI scanning including claustrophobia, high girth, moderate to significant white matter atrophy, and presence of ferromagnetic material in the body, including orthodo…
Inclusion Criteria:
* able to give written informed consent
* age 55+
* English speaking
Exclusion Criteria:
* contraindication to MRI scanning including claustrophobia, high girth, moderate to significant white matter atrophy, and presence of ferromagnetic material in the body, including orthodontic braces or other non MR-compatible foreign bodies. All participants will be screened for metal objects by the same methods used for routine clinical MRI scanning
* for women: pregnancy or breastfeeding
* serious medical or neurological illness that in the opinion of the PI would interfere with the scientific goals of the study or participant safety
* pervasive developmental disorders (PDD) or primary psychotic disorders
* meet DSM-5 criteria for current severe substance use disorder (except marijuana or nicotine)
* head injury that led to significant long term decline in cognitive abilities as seen by decline in grades or work performance
* current psychosis, active significant suicidal (score of 6 on MADRS suicide item) or homicidal ideation
* lifetime history of neurologic abnormality including seizure disorder, cerebrovascular, or neoplastic lesion, neurodegenerative disorder, or significant head trauma resulting in post-traumatic amnesia \>24 hours
* full scale IQ lower than 70
* contraindications to PET (e.g. poor venous access for placement of venous lines)
* history of prior radiation exposure for research purposes within the past year such that participation in this study would place them over FDA limits for annual radiation exposure. This guideline is an effective dose of 5 rem received per year
* history of a bleeding disorder or currently taking anticoagulants (such as Coumadin, Heparin, Pradaxa, Xarelto) \*for subjects obtaining arterial line.
* blood donation within 8 weeks of the start of the study
* REM sleep disorder
* brain injury (TBI, seizure/epilepsy, stroke, TIA) in lifetime (self-report and medical chart review)
* electroconvulsive or ketamine therapy, or similar therapies that have rapid effects on brain neurochemistry within the past 6 months
* high risk for stroke (above first quartile on Framingham Stroke Risk Profile)
* current cancer
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.